PetVivo (NASDAQ:PETV – Get Free Report) is projected to release its resultson Thursday, November 12th. Analysts expect PetVivo to announce earnings of ($0.08) per share and revenue of $0.01 million for the quarter.
PetVivo Stock Performance
PETV stock opened at $0.60 on Thursday. The company has a quick ratio of 0.47, a current ratio of 0.42 and a debt-to-equity ratio of 0.02. The company has a market capitalization of $23.06 million, a price-to-earnings ratio of -1.33 and a beta of 1.33. PetVivo has a 12 month low of $0.54 and a 12 month high of $1.44. The firm has a 50 day moving average of $0.72 and a two-hundred day moving average of $0.76.
PetVivo Company Profile
PetVivo Holdings, Inc is a biomedical company focused on developing and commercializing medical therapeutics and devices for use in animals and, potentially, humans. The company’s technologies are designed to address conditions involving damaged or diseased tissue, with an emphasis on minimally invasive treatments.
PetVivo’s principal commercial product is Spryng with OsteoCushion Technology, an injectable product administered by veterinary professionals. It is intended to help manage lameness associated with osteoarthritis and other joint-related conditions in animals, including dogs and horses.
Read More
- Five stocks we like better than PetVivo
- Why ExxonMobil and Chevron Reminded Investors to Keep it Simple
- Amazon Has Erased Its Earnings Sell-Off, But Is the Biggest Opportunity Still Ahead?
- onsemi’s AI Sales Surge 175%: Is a Stock Recovery Next?
- Energy Transfer’s Earnings Miss May Be Hiding Its Strongest Advantage
Receive News & Ratings for PetVivo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PetVivo and related companies with MarketBeat.com's FREE daily email newsletter.
